Richard Jacinto II - 30 Sep 2025 SCHEDULE 13G/A Report for DiaMedica Therapeutics Inc. Voting Common Shares, no par value (DMAC)

Filing Manager: Richard Jacinto II
Reporting Manager: Richard Jacinto II
Security: DiaMedica Therapeutics Inc. Voting Common Shares, no par value
Symbol: DMAC
Shares outstanding: 51.7M shares
Disclosed Ownership: 4.96M shares
Ownership: 9.6%
Form type: SCHEDULE 13G/A
Filing time: 07 Nov 2025, 17:30:12 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Richard Jacinto II	9.6%	4.96M	4.96M	0	/s/ Richard Jacinto II	Richard Jacinto II